BREAKING DOWN BOUNDARIES WITH CANCER BREAKTHROUGHS

tation. That means creating three “minority-majority” districts, that would allow minority communities a chance to elect someone who would be more likely to represent them on the town board.

For example, 90 percent of Elmont’s population are people of color. However, the current map proposal places Elmont in a district with Garden City, which has an 88 percent white population.

Placing Elmont in a district with neighborhoods they have nothing in common with dilutes the votes of its residents and impairs the outcome of elections, claimed Claudia Borecky, president of the Bellmore Merrick Democratic Club, in a letter to the Hempstead Town Board.

“People told heart-wrenching stories of how hard they and their ancestors fought for the right to have a vote that counted,” Borecky said. “Yet, the motion made by the redistricting commission for the Town Board to only consider keeping communities whole is totally deaf to what your constituents plead.”

Under the guidance of the Troutman Pepper Hamilton Sanders law firm and redistricting expert Sean Trende, the Town Board released a redistricting map proposal last month, which they say takes into account public comments as well as the views of the redistricting commission.

However, some doubted these intentions.

“If (the town) passes this map, I’m going to Garden City because that’s my district,” Pierre-Johnson said. “I’m going to show up with my friends to (Garden City) town meetings, to the zoning board, because I want what they have for Elmont.”

Critics also questioned the map’s compliance with federal and state voting rights protections — specifically the Voting Rights Act and New York’s John R. Lewis Voting Rights Act. If Hempstead finalizes the current map as it stands, it could expose the town to costly litigation at the taxpayers’ expense.

LIJ Medical Center is in the top 10% of hospitals nationally for oncology, according to U.S.News&WorldReport.

Our doctors are raising health by pioneering innovative approaches to cancer from novel chemotherapy techniques to first-in- the-nation robotic mastectomies with minimal scarring. Because when it comes to cancer, there’s no status quo. There’s only “how far can we go?”

Northwell.edu/NoLimits